Kraig Biocraft Laboratories (KBLB) EBT Margin (2016 - 2018)

Kraig Biocraft Laboratories has disclosed EBT Margin across 3 years of filings, most recently posting 147.04% for Q3 2018.

• EBT Margin for Q3 2018 came in at 147.04%, up 88075.0% year-over-year; the trailing twelve-month figure through Jun 2019 was 1123.68% (down 83161.0% YoY), and the FY2021 annual result was 20114507.5%, changed N/A from the prior year.
• EBT Margin came in at 147.04% for Q3 2018 at Kraig Biocraft Laboratories, down from 123.88% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 123.88% in Q2 2018 to a low of 6919.46% in Q4 2016.
• The 3-year median for EBT Margin is 426.32% (2017), against an average of 2131.88%.
• Across the five-year window, EBT Margin surged 649314 bps in 2017 and surged 88075 bps in 2018, its largest moves.
• Kraig Biocraft Laboratories' EBT Margin stood at 6919.46% in 2016, then jumped by 94 bps to 426.32% in 2017, then surged by 66 bps to 147.04% in 2018.
• The last three EBT Margin figures came in at 147.04% (Q3 2018), 123.88% (Q2 2018), and 256.77% (Q1 2018), per Business Quant data.